Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Confluent

Steve Cohen's Point72 Goes Heavy on Tech and Pharma Stocks, Investing Over $330M in Two Trades

Point72 Asset Management recently purchased over 10 million shares of Confluent and Amylyx Pharma common stock, worth more than $334.17 million.

International Business Times UK

1 Under-the-Radar AI Stock With 50% Upside Potential

This high-risk, high-reward growth opportunity deserves some attention.

Barchart

Confluent: How Data Streaming May Transform AI

Confluent's earnings performance, its strong guidance, and its exciting partnership with Databricks—with the potential to transform AI—make it a must-watch.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

The Future of Innovation: 3 Tech Stocks to Watch

Confluent, SentinelOne, and Coupang are transforming data management, security, and e-commerce with innovative solutions and impressive growth.

MarketBeat

The Latest Analyst Ratings For Confluent

20 analysts have shared their evaluations of Confluent (NASDAQ:CFLT) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

UK CEOs ignore IT data when making big decisions

Three in five leaders make snap decisions without consulting data, but they recognize the importance of real-time dashboards.

TechRadar

2 Magnificent Growth Stocks to Buy Under $30 and Hold Forever

Even a small investment in great stocks could yield significant long-term returns.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Scoop Up this Growth Stock Now for 38% Upside Potential

This software stock has underperformed, but now trades at an attractive valuation after its latest Q2 earnings beat.

Barchart

1 Standout Tech Stock That Short Sellers Are Targeting

This mid-cap tech stock has been heavily targeted by short sellers lately. Is this analyst favorite growth stock setting up for a short-squeeze rally?

Barchart

Scoop Up This Disruptive Growth Stock for 22% Upside

As businesses continue to harness the power of real-time data processing and analytics, Confluent is well-positioned to ride this wave of growth and innovation.

Barchart

3 Growth Stocks Under $200 to Buy and Hold Forever

Even a small investment in the right stocks can result in significant wealth over time.

Barchart

My Top 2 Tech Picks Under $30 for 2024

The Street-high target prices suggest these rising tech stars have 48% to 70% upside from here.

Barchart

2 Growth Stocks Under $40 to Scoop Up Now

These hypergrowth stocks have the potential to generate higher-than-average returns for investors over the long term.

Barchart

Confluent Stock Surges 41% YTD On Strong Q4 Results

Confluent's strong performance and strategic focus position it as a key player in real-time data solutions.

Top News

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Software Stocks Analysts Like Better Than Palantir

Palantir has had a remarkable rally so far in 2023. However, there are three other software stocks that analysts believe have more upside from current levels.

Benzinga

What 8 Analyst Ratings Have To Say About Confluent

Analysts have provided the following ratings for Confluent (NASDAQ:CFLT) within the last quarter:

Benzinga

HubSpot And 2 Other Stocks Insiders Are Buying

Although the Dow Jones dipped sharply by over 1,150 points on Wednesday, there were a few notable insider trades.

Benzinga

Expert Ratings for Confluent

Within the last quarter, Confluent (NASDAQ:CFLT) has observed the following analyst ratings:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Insiders Buy More Than $15M Of 3 Stocks

Although US stock futures traded higher this morning on Thursday, there were a few notable insider trades.

Benzinga

Analyst Ratings for Confluent

Analysts have provided the following ratings for Confluent (NASDAQ:CFLT) within the last quarter:

The Hindu

Medical devices maker Confluent sets up pilot plant

Company chooses Hyderabad for India foray, to manufacture Nitinol products

Benzinga

What 7 Analyst Ratings Have To Say About Confluent

Confluent (NASDAQ:CFLT) has observed the following analyst ratings within the last quarter:

Benzinga

What 8 Analyst Ratings Have To Say About Confluent

Within the last quarter, Confluent (NASDAQ:CFLT) has observed the following analyst ratings:

Benzinga

Analyst Ratings For Confluent

Analysts have provided the following ratings for Confluent (NASDAQ:CFLT) within the last quarter:

Benzinga

Why Confluent Shares Are Falling

Confluent Inc (NASDAQ: CFLT) shares are trading lower by 9.3% at $66.38 Friday morning after the company reported fourth-quarter earnings results.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.